Analytical Data
-
Gene name
TTC35
- Application
-
Alternative Names
EMC2; KIAA0103; TTC35ER membrane Protein complex subunit 2; Tetratricopeptide repeat Protein 35; TPR repeat Protein 35
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q15006
-
Expression Region
2-297 aa
-
AA Sequence
AKVSELYDV TWEEMRDKMR KWREENSRNS EQIVEVGEEL INEYASKLGD DIWIIYEQVM IAALDYGRDD LALFCLQELR RQFPGSHRVK RLTGMRFEAM ERYDDAIQLY DRILQEDPTN TAARKRKIAI RKAQGKNVEA IRELNEYLEQ FVGDQEAWHE LAELYINEHD YAKAAFCLEE LMMTNPHNHL YCQQYAEVKY TQGGLENLEL SRKYFAQALK LNNRNMRALF GLYMSASHIA SNPKASAKTK KDNMKYASWA ASQINRAYQF AGRSKKETKY SLKAVEDMLE TLQITQS
-
Molecular Weight
34.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TTC35, or Tetratricopeptide repeat-containing protein 35, has emerged as a significant focus of research due to its potential roles in various cellular processes, including protein-protein interactions and cellular signaling pathways. It is characterized by a unique structure that allows it to interact with a variety of proteins, suggesting its involvement in complex regulatory networks. Recent studies have indicated that TTC35 can influence important biological functions, such as cell cycle regulation, apoptosis, and stress response mechanisms. Additionally, its differential expression in various tissues and its association with certain diseases, including cancer and neurodegenerative disorders, have sparked interest in understanding the molecular mechanisms underlying its function. Researchers are employing advanced techniques such as recombinant protein expression and purification to explore TTC35's structure-function relationships and its potential as a therapeutic target. By elucidating the role of TTC35 in health and disease, scientists aim to provide insights that could lead to innovative strategies for diagnosis and treatment, ultimately enhancing our understanding of its biological relevance in the human body.
